SCHEDULE 13G Filed 2026-07-20 Event — SEC 0000902664-26-003172 →

Lynx1 Capital Management LP → PRECISION BIOSCIENCES INC DTIL

Stake: — Shares: — Class: Common Stock, par value $0.000005 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (8.8 DTC)
Short interest building (+13.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

11 transactions

6 buys · 0 sales · 5 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 8.81

2,514,044 shares short · +13.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $123K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-25	Brown Melinda	director	Buy	1,135	$6.27	$7K
2026-06-03	Brown Melinda	director	Award	20,979	—	—
2026-06-03	Frankel Stanley	director	Award	20,979	—	—
2026-06-03	Germano Geno J	director	Award	20,979	—	—
2026-06-03	Pire Shari Lisa	director	Award	20,979	—	—
2026-06-03	Buehler Kevin	director	Award	20,979	—	—
2026-05-20	Buehler Kevin	director	Option exercise	21,000	—	—
2026-05-20	Frankel Stanley	director	Option exercise	21,000	—	—
2026-05-20	Brown Melinda	director	Option exercise	21,000	—	—
2026-05-20	Pire Shari Lisa	director	Option exercise	21,000	—	—
2026-05-20	Germano Geno J	director	Option exercise	21,000	—	—

Other 13D/G Filings on PRECISION BIOSCIENCES INC

Filed	Form	Filer	Stake	Shares
2020-07-09	SC	venBio Global Strategic Fund, L.P.	—	—	view →
2020-06-24	SC	venBio Global Strategic Fund, L.P.	—	—	view →
2020-06-08	SC	venBio Global Strategic Fund, L.P.	—	—	view →

Other Filings by Lynx1 Capital Management LP

Filed	Form	Issuer	Stake	Shares
2026-07-02	SCHEDULE 13D	Passage BIO, Inc. PASG	21.00%	673,759	view →
2025-12-29	SCHEDULE	Neuphoria Therapeutics Inc. NEUP	16.30%	875,328	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →